Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

41 study records (showing up to 30 per record type)

• Registered trial NCT06131918 Phase 2 Completed (results not assessed here)
  Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy
  Condition or outcome area: Peripheral Diabetic Neuropathy
  2023-01-09 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05913986 Not completed: Recruiting
  Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease
  Condition or outcome area: Metabolic Associated Fatty Liver Disease
  2023-03-01 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05729529 Not completed: Recruiting
  Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
  Condition or outcome area: Burning Mouth Syndrome
  2020-01-20 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05813496 Phase 4 Not completed: Recruiting
  Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt
  Condition or outcome area: Polyneuropathy, Diabetic
  2022-10-26 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT06151652 Phase 4 Not completed: Recruiting
  Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients
  Condition or outcome area: Postoperative Atrial Fibrillation
  2023-01-01 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT06056687 Completed (results not assessed here)
  Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
  Condition or outcome area: Ischemic Cardiomyopathy|Diabetes Mellitus
  2023-03-01 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05808946 Phase 2 / Phase 3 Not completed: Recruiting
  Alpha-Lipoic Acid in Patients With Sepsis
  Condition or outcome area: Sepsis
  2023-03-10 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05913986 Not completed: Recruiting
  Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease
  Condition or outcome area: Metabolic Associated Fatty Liver Disease
  2023-03-01 · Subject: Shui Fei Ji; 水飞蓟; Silybum Marianum;Fruit Of Silybum Marianum; Silybi Fructus;Fructus Silybi · open the herb record · ClinicalTrials.gov
• Registered trial NCT05485259 Completed (results not assessed here)
  Effect of Alpha-lipoic Acid on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL)
  Condition or outcome area: Low-Grade Squamous Intraepithelial Lesions
  2020-01-15 · Subject: Alpha-Lipoic Acid; Thioctic acid; α-lipoicacid; 5-[1,2]-dithiolan-3-yl-pentanoic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04881851 Not completed: Recruiting
  Effects of Inositol Alone or Associated With Alpha-lipoic Acid in Polycystic Ovary Syndrome Treatment
  Condition or outcome area: Polycystic Ovary Syndrome
  2015-05-07 · Subject: Myoinositol; Inositol; inositol b; D-myo-inositol; D-Chiro-Inositol; cocositol; Chiro-inositol; inositol c; KS-00001292; TR-022051 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02651636 Completed (results not assessed here)
  Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
  Condition or outcome area: Polycystic Ovary Syndrome|Menstrual Pattern|Hyperandrogenism|Metabolic Features
  2014-06 · Subject: Myoinositol; Inositol; inositol b; D-myo-inositol; D-Chiro-Inositol; cocositol; Chiro-inositol; inositol c; KS-00001292; TR-022051 · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42023467716 Registered protocol, no results here: Review Ongoing
  Effect of alpha lipoic acid supplementation on migraine treatment: A systematic review
  Condition or outcome area: Migraine is defined as a common, chronic, throbbing, weakening neurological disease, accompanied by a serious one-sided headache, nausea, vomiting, and photophobia. The exact pathophysiological mechanisms of migraine are not completely understood. However, according to studies, several hypotheses have been proposed in the pathogenesis of migraine. One of the recognized hypotheses on migraine is hypoxia or mitochondrial dysfunction; Hypoxia and mitochondrial dysfunction increase lactate levels in
  2023-10-08 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023461612 Registered protocol, no results here: Review Ongoing
  The effect of alpha-lipoic acid supplementation in patients with stroke: a systematic review and meta-analysis of interventional and observational studies
  Condition or outcome area: In patients with stroke
  2023-09-18 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023456959 Registered protocol, no results here: Review Ongoing
  Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in terms of Efficacy and Safety in the management of Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta- Analysis
  Condition or outcome area: Diabetic Neuropathy (DN) contributes to 32 to 53% of peripheral neuropathies. Hyperglycemia, whether in overt or prediabetic patients may cause DN. While glycemic control is effective in preventing and slowing the progression of DSPN and PDN among type 1 DM patients, its effect among T2DM patients is only modest and reversal of neuronal loss is generally not achievable.At most, symptomatic relief of pain with the use of gabapentinoids like pregabalin and gabapentin; serotonin and norepinephrine
  2023-09-02 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023453955 Registered protocol, no results here: Review Ongoing
  The Efficacy of Alpha Lipoic Acid in Nonalcoholic Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta Analysis of Clinical Trials
  Condition or outcome area: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with a prevalence of 25% and characterized by different stages of progression such as non-alcoholic fatty liver (NAFL) (steatosis) and nonalcoholic steatohepatitis (NASH), that leads to cirrhosis. NAFLD and NASH are related to insulin resistance and metabolic syndrome. Some animal studies suggested that alpha-lipoic acid (ALA) can improve these disease outcomes. In addition, there is evidence of beneficial effects of ALA
  2023-08-24 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023453457 Registered protocol, no results here: Review Ongoing
  Assessing the Efficacy of Alpha-Lipoic Acid in Managing Diabetic Neuropathy: A Comprehensive Systematic Review
  Condition or outcome area: The focus of this systematic review is to assess the effect of alpha-lipoic acid in the treatment of diabetic neuropathy. Diabetic neuropathy refers to nerve damage arising from prolonged hyperglycemia in individuals with diabetes mellitus, leading to a range of sensory, motor, and autonomic symptoms. This review aims to analyze the potential therapeutic role of alpha-lipoic acid in alleviating neuropathic symptoms and its implications for managing diabetic neuropathy.
  2023-08-26 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023448233 Registered protocol, no results here: Review Ongoing
  Efficacy of alpha-lipoic acid in reducing drug-induced neurotoxicity.
  Condition or outcome area: Although there are numerous studies that prove the safety of drugs, there are still several side effects that are not avoidable, such as neurotoxicity. Many studies focus on changing doses, adding medications, but leave aside the option of including nutraceuticals, which are proven to have an antioxidant effect, which can reduce the toxicity caused by medications. In fact, most studies with nutraceuticals do not bring alarming results, but on the other hand, the fact that they have few or no sid
  2023-08-05 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023447658 Registered protocol, no results here: Review Ongoing
  The effect of Alpha lipoic acid (ALA) on blood pressure: A systematic review and dose-response meta-analysis ofrandomized clinical trials
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic non-communicable disease such ascardiovascular disorders, dyslipidemia, hypercholesterolemia, metabolic syndrome
  2023-08-02 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023446824 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of the effects of plant-based substances and nutritional supplements therapy on tinnitus severity perception in adult patients
  Condition or outcome area: Tinnitus in adults with chronic or acute tinnitus through these domains: a) Tinnitus severity measured through subjective assessment of tinnitus severity, frequency or annoyance using visual analogue scales (VAS). b) Tinnitus loudness can be measured through performance-based procedures such as tinnitus loudness or pitch matching. c) The impact of tinnitus on patients’ daily life can be measured on standardized self-reported questionnaires.
  2023-07-31 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023443022 Registered protocol, no results here: Review Ongoing
  Effects of lipoic acid supplementation on lipid profile, oxidative stress biomarkers, leptin and adiponectin in gestational diabetes; a systematic review and meta-analysis
  Condition or outcome area: Pregnant women with gestational diabetes will be included.
  2023-07-17 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023430674 Registered protocol, no results here: Review Ongoing
  The role of dietary supplements in migraine prevention: A comprehensive systematic review and dose-response meta-analysis of randomized controlled trials
  Condition or outcome area: Effect of riboflavin, magnesium, vitamin D, Q10, omega-3, alpha lipoic acid, probiotic on migraine prevention in adults.
  2023-06-09 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023427856 Registered protocol, no results here: Review Ongoing
  Alpha-lipoic Acid Supplementation for Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
  Condition or outcome area: Alpha-lipoic acid (ALA) is a short-chain fatty acid known for its antioxidant properties. Some studies suggest that ALA may be used as an anti-inflammatory supplement in the setting of NAFLD, however data is largely limited to animal models and is notably contradictory. While some studies demonstrate improvement in inflammatory markers with the use of ALA , others report neutral effects of the supplement. Therefore, it is difficult to conclude whether or not ALA should be regularly prescribed to
  2023-05-31 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023423175 Registered protocol, no results here: Review Ongoing
  Efficacy of per orem intake of thioctic acid in diabetic peripheral neuropathy: A systematic review and Meta Analysis
  Condition or outcome area: Diabetic neuropathy (DN) is a common complication of diabetes, with the most prevalent type as distal polyneuropathy causing significant discomfort and impairment of quality of life. Clinical guidelines recommend several strategies for these based on the best available evidence. Recent studies have shown efficacy of per orem intake of alpha lipoic acid or thioctic acid in the management of DN. Therefore, we performed a meta-analysis of randomized controlled trials (RCTs) to examine the quality o
  2023-05-16 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023422189 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of the Alpha-Lipoic Acid effects on metabolic parameters of PCOS patients
  Condition or outcome area: Women with polycystic ovary syndrome
  2023-05-08 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023418851 Registered protocol, no results here: Review Ongoing
  Efficacy of using Alpha Lipoic acid supplement in Patients with Diabetic Neuropathy : A Systematic Review
  Condition or outcome area: Diabetes mellitus is a major public health problem, reaching epidemic proportions globally. Approximately 9% of adults are estimated to be affected by diabetes worldwide, however, around half of the cases remain undiagnosed. And one of the most common and costly microvascular complications of diabetes mellitus (DM) is diabetic neuropathy (DN), which, of note, is usually underdiagnosed and undertreated in every day clinical practice. The most common forms of DN are diabetic distal symmetrical sen
  2023-04-30 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42023483534 Registered protocol, no results here: Review Ongoing
  The effectiveness of nutrition supplements in improving in women with polycystic ovary syndrome: A systematic review and network meta-analysis.
  Condition or outcome area: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries. 4–10% of reproductive-age women are predicted to have PCOS worldwide. The pathophysiology of PCOS is chiefly concerned with hormonal imbalance, chronic low-grade inflammation, insulin resistance, and hyperandrogenism, which impair folliculogenesis and increase the risk of related comorbidities. Several clinical s
  2023-11-27 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018107320 Registered protocol, no results here: Review Ongoing
  Affect of alpha-lipoic acid on serum level of inflammatory mediators: a meta-analysis and systematic review on randomized controlled trials
  Condition or outcome area: The enhancement of oxidative stress and inflammation increases the risk of chronic health condition. The body protects itself against injury and insults by inflammation, but persistence inflammation produces mediators by activated immune cells which lead to disease development and tissue injuries. The increased level of inflammation can be revealed by measuring inflammatory biomarkers such as TNF-a, C-reactive protein (CRP), and IL-6. Reducing inflammation by therapeutic strategies dramatically
  2018-09-04 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42019105933 Registered protocol, no results here: Review Completed published
  Evaluating the lipid-lowering effects of alpha-lipoic acid supplementation: a systematic review
  Condition or outcome area: This review is assessing the efficacy of alpha-lipoic acid as a lipid lowering dietary supplement. Lipid lowering may be assessed as a change from baseline measurements which may or may not be above clinical cut-offs. Basically, above optimal total cholesterol, LDL cholesterol and triglycerides and/or lower than optimal HDL cholesterol are being considered.
  2019-01-25 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018088903 Registered protocol, no results here: Review Ongoing
  Tolerability and efficacy of alpha-lipoic acid for the management of diabetes mellitus: a systematic review and meta-analysis
  Condition or outcome area: Tolerability and efficacy of alpha-lipoic acid for the management of diabetes mellitus.
  2018-02-19 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018088480 Registered protocol, no results here: Review Ongoing
  Effectiveness of alpha-lipoic acid supplementation for patients with coronary heart disease
  Condition or outcome area: Alpha-lipoic acid supplementation Alpha-lipoic acidsupplementation for patients with coronary heart disease
  2018-02-23 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018088479 Registered protocol, no results here: Review Ongoing
  The effectiveness of alpha-lipoic acid supplementation for type 2 diabetes patients
  Condition or outcome area: Alpha-lipoic acid supplementation for type 2 diabetes patients.
  2018-02-14 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018088476 Registered protocol, no results here: Review Ongoing
  The effectiveness of alpha-lipoic acid supplementation for type 1 diabetes patients
  Condition or outcome area: Alpha-lipoic acid supplementation for type 1 diabetes patients.
  2018-02-13 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018086769 Registered protocol, no results here: Review Ongoing
  Effectiveness of alpha-lipoic acid supplementation for rheumatoid arthritis patients
  Condition or outcome area: Alpha-lipoic acid supplementation Alpha-lipoic acid supplementation for rheumatoid arthritis patients
  2018-01-29 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42021233878 Registered protocol, no results here: Review Ongoing
  The effects of Alpha-Lipoic acid supplementation on lipid profile: An updated systematic review anda dose-response meta-analysis of randomized clinical trials
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic non-communicable disease such as cardiovascular disorders dyslipidemia, hypercholesterolemia, metabolic syndrome
  2021-02-28 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42020212501 Registered protocol, no results here: Review Ongoing
  Effects of alpha-lipoic acid supplementation on non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials
  Condition or outcome area: Non-alcoholic fatty liver diseases (NAFLD)
  2020-11-02 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42018091243 Registered protocol, no results here: Review Ongoing
  Does alpha-lipoic acid affect lipid profile: a meta-analysis and systematic review on randomized clinical trials
  Condition or outcome area: In recent years, chronic diseases such as Cardiovascular disease (CVD) are major contributors to global mortality. The total number of death caused by CVD indicated globally increase to 17.5 million in year 2005 from 14.4 million in year 1990. The enhancement of lipid profile and the reduction of HDL are risk factors for CVD. According to new evidence taking some food supplements instead of medicine can be protective against CVD risk factors. Scientists believe alpha-lipoic acid might reduce lip
  2018-03-19 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42020180241 Registered protocol, no results here: Review Ongoing
  The effects of Alpha-Lipoic acid supplementation on glycemic markers: An updated systematic review and dose-response meta-analysis of randomized clinical trials
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic non-communicable disease such as cardiovascular disorders dyslipidemia, hypercholesterolemia, metabolic syndrome.
  2020-07-05 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42020180226 Registered protocol, no results here: Review Ongoing
  The effects of Alpha-Lipoic acid supplementation on inflammation markers: An updated systematic review and dose-response meta-analysis of randomized clinical trials
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic non-communicable disease such as cardiovascular disorders dyslipidemia, hypercholesterolemia, metabolic syndrome.
  2020-07-05 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42020178466 Registered protocol, no results here: Review Ongoing
  Effects of inositol and alpha-lipoic acid combination in women with polycystic ovary syndrome: a systematic review and meta-analysis
  Condition or outcome area: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. It is characterized by ovulatory dysfunction, hyperandrogenism and polycystic ovaries. Insulin resistance and oxidative stress play a pivotal role in the pathophysiology of PCOS. Therefore, we will conduct a systematic review to evaluate the effectiveness and safety of inositol and alpha-lipoic acid combination, with a focus on clinical, metabolic and endocrine dysfunctions in women suffering from polyc
  2020-07-05 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42020165857 Registered protocol, no results here: Review Ongoing
  The effects of Alpha-Lipoic acid supplementation on obesity measures: An updated systematic review and dose-response meta-analysis of randomized clinical trials
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic metabolic non-communicable disease such as cardiovascular disorders dyslipidemia, hypercholesterolemia, metabolic syndrome.
  2020-04-28 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record
• Systematic review registration CRD42019145592 Registered protocol, no results here: Review Completed published
  Effect of oral alpha-lipoic acid on the treatment of male infertility: a systematic review and meta-analysis
  Condition or outcome area: There are approximately 200 million infertile patients worldwide, and male infertility accounts for about 50%. The literature suggests that many reasons can lead to male infertility. Oral alpha-lipoid acid is currently widely used in the treatment of people with diabetes mellitus. Recent studies have found that alpha-lipoic acid can improve male fertility. At the same time, as an antioxidant, some studies have also found that alpha-lipoic acid can improve the quality of male sperm, thereby impro
  2019-11-05 · Subject: Alpha-lipoic acid; Thioctic acid; thioctic acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; alpha Lipoic Acid; Biletan · open the ingredient record